70
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Range Verification Methods in Particle Therapy: Underlying Physics and Monte Carlo Modeling

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hadron therapy allows for highly conformal dose distributions and better sparing of organs-at-risk, thanks to the characteristic dose deposition as function of depth. However, the quality of hadron therapy treatments is closely connected with the ability to predict and achieve a given beam range in the patient. Currently, uncertainties in particle range lead to the employment of safety margins, at the expense of treatment quality. Much research in particle therapy is therefore aimed at developing methods to verify the particle range in patients. Non-invasive in vivo monitoring of the particle range can be performed by detecting secondary radiation, emitted from the patient as a result of nuclear interactions of charged hadrons with tissue, including β + emitters, prompt photons, and charged fragments. The correctness of the dose delivery can be verified by comparing measured and pre-calculated distributions of the secondary particles. The reliability of Monte Carlo (MC) predictions is a key issue. Correctly modeling the production of secondaries is a non-trivial task, because it involves nuclear physics interactions at energies, where no rigorous theories exist to describe them. The goal of this review is to provide a comprehensive overview of various aspects in modeling the physics processes for range verification with secondary particles produced in proton, carbon, and heavier ion irradiation. We discuss electromagnetic and nuclear interactions of charged hadrons in matter, which is followed by a summary of some widely used MC codes in hadron therapy. Then, we describe selected examples of how these codes have been validated and used in three range verification techniques: PET, prompt gamma, and charged particle detection. We include research studies and clinically applied methods. For each of the techniques, we point out advantages and disadvantages, as well as clinical challenges still to be addressed, focusing on MC simulation aspects.

          Related collections

          Most cited references156

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Big-Bang Nucleosynthesis

          A critical review is given of the current status of cosmological nucleosynthesis. In the framework of the Standard Model with 3 types of relativistic neutrinos, the baryon-to-photon ratio, \(\eta\), corresponding to the inferred primordial abundances of deuterium and helium-4 is consistent with the independent determination of \(\eta\) from observations of anisotropies in the cosmic microwave background. However the primordial abundance of lithium-7 inferred from observations is significantly below its expected value. Taking systematic uncertainties in the abundance estimates into account, there is overall concordance in the range \(\eta = (5.7-6.7)\times 10^{-10}\) at 95% CL (corresponding to a cosmological baryon density \(\Omega_B h^2 = 0.021 - 0.025\)). The D and He-4 abundances, when combined with the CMB determination of \(\eta\), provide the bound \(N_\nu=3.28 \pm 0.28\) on the effective number of neutrino species. Other constraints on new physics are discussed briefly.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Statistics and Nuclear Reactions

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer.

              Proton therapy treatments are based on a proton RBE (relative biological effectiveness) relative to high-energy photons of 1.1. The use of this generic, spatially invariant RBE within tumors and normal tissues disregards the evidence that proton RBE varies with linear energy transfer (LET), physiological and biological factors, and clinical endpoint. Based on the available experimental data from published literature, this review analyzes relationships of RBE with dose, biological endpoint and physical properties of proton beams. The review distinguishes between endpoints relevant for tumor control probability and those potentially relevant for normal tissue complication. Numerous endpoints and experiments on sub-cellular damage and repair effects are discussed. Despite the large amount of data, considerable uncertainties in proton RBE values remain. As an average RBE for cell survival in the center of a typical spread-out Bragg peak (SOBP), the data support a value of ~1.15 at 2 Gy/fraction. The proton RBE increases with increasing LETd and thus with depth in an SOBP from ~1.1 in the entrance region, to ~1.15 in the center, ~1.35 at the distal edge and ~1.7 in the distal fall-off (when averaged over all cell lines, which may not be clinically representative). For small modulation widths the values could be increased. Furthermore, there is a trend of an increase in RBE as (α/β)x decreases. In most cases the RBE also increases with decreasing dose, specifically for systems with low (α/β)x. Data on RBE for endpoints other than clonogenic cell survival are too diverse to allow general statements other than that the RBE is, on average, in line with a value of ~1.1. This review can serve as a source for defining input parameters for applying or refining biophysical models and to identify endpoints where additional radiobiological data are needed in order to reduce the uncertainties to clinically acceptable levels.
                Bookmark

                Author and article information

                Contributors
                URI : http://frontiersin.org/people/u/205811
                Journal
                Front Oncol
                Front Oncol
                Front. Oncol.
                Frontiers in Oncology
                Frontiers Media S.A.
                2234-943X
                07 July 2015
                2015
                : 5
                : 150
                Affiliations
                [1] 1Department of Physics, National Institute for Nuclear Physics (INFN), University of Pisa , Pisa, Italy
                Author notes

                Edited by: Marco Durante, GSI Helmholtzzentrum für Schwerionenforschung, Germany

                Reviewed by: Lembit Sihver, Technische Universität Wien, Austria; Francesco Cerutti, CERN, Switzerland

                *Correspondence: Aafke Christine Kraan, Department of Physics, INFN, University of Pisa, Largo B. Pontecorvo 3, Pisa 56127, Italy, aafke.kraan@ 123456pi.infn.it

                Specialty section: This article was submitted to Radiation Oncology, a section of the journal Frontiers in Oncology

                Article
                10.3389/fonc.2015.00150
                4493660
                26217586
                80e97762-e344-4701-ae44-e89150117457
                Copyright © 2015 Kraan.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 24 February 2015
                : 17 June 2015
                Page count
                Figures: 14, Tables: 1, Equations: 11, References: 197, Pages: 27, Words: 21406
                Funding
                Funded by: Galileo Galilei School
                Funded by: University of Pisa
                Funded by: INFN Pisa
                Categories
                Oncology
                Review

                Oncology & Radiotherapy
                hadron interactions,monte carlo modeling,range verification,pet,prompt gamma

                Comments

                Comment on this article